Concepedia

Angiotensin II receptor blocker inhibits abnormal accumulation of advanced glycation end products and retinal damage in a rat model of type 2 diabetes

Tetsuya Sugiyama, Takashi Okuno, Masayuki Fukuhara, Hidehiro Oku, Tsunehiko Ikeda, Hiroshi Obayashi, Mitsuhiro Ohta, Michiaki Fukui, Goji Hasegawa, Naoto Nakamura

Experimental Eye Research · 2007 · 59 citations · 28 references

DOI

Concepts

References

28

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

BMJ · 1998 · 6.7K citations · Full text

, , +16

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

M R Stearne, S L Palmer, M S Hammersley et al. · 1998 · 4.8K citations

, , +16

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

Lloyd Paul Aiello, Robert L. Avery, Paul G. Arrigg et al. · New England Journal of Medicine · 1994 · 3.8K citations · Full text

, , +15

Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy

A.P. Adamis, Joan W. Miller, Teresa Bernal et al. · American Journal of Ophthalmology · 1994 · 1.3K citations

, , +13

Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging.

Helen Vlassara, Richard Bucala, Liliane J. Striker · PubMed · 1994 · 853 citations

, , +16